All Updates

All Updates

icon
Filter
Funding
XtalPi goes public in Hong Kong; raises USD 127 million in IPO funding
AI Drug Discovery
Jun 11, 2024
This week:
Partnerships
Anthropic partners with Amazon Bedrock to fine-tune Claude 3 Haiku model
Foundation Models
Yesterday
Funding
Lemon.markets raises EUR 12 million in funding to support growth
FinTech Infrastructure
Yesterday
M&A
Kipu Quantum acquires PlanQK platform to enhance accessibility to quantum computing solutions
Quantum Computing
Yesterday
Partnerships
Quantinuum and STFC Hartree Centre partner to enhance quantum computing accessibility in UK
Quantum Computing
Yesterday
M&A
Ipsen licenses Foreseen's antibody-drug conjugate 'FS001' for first-in-class cancer treatment development
Precision Medicine
Yesterday
M&A
Ipsen licenses Foreseen's antibody-drug conjugate 'FS001' for first-in-class cancer treatment development
AI Drug Discovery
Yesterday
Partnerships
Beacon Therapeutics collaborates with Abeona Therapeutics for ophthalmic gene therapy development
Cell & Gene Therapy
Yesterday
Funding
Pan Cancer T raises EUR 4.25 million in seed extension funding for preclinical studies of PCT1:CO-STIM TCR T-cell therapy
Cell & Gene Therapy
Yesterday
Partnerships
Accelerated Biosciences and Pluristyx partner to create clinical-grade induced pluripotent stem cell lines
Cell & Gene Therapy
Yesterday
M&A
SoftBank acquires UK AI chipmaker Graphcore to improve AI capabilities
Edge Computing
Yesterday
AI Drug Discovery

AI Drug Discovery

Jun 11, 2024

XtalPi goes public in Hong Kong; raises USD 127 million in IPO funding

Funding

  • Google-backed AI drug discovery company XtalPi, also known as QuantumPharm, debuted on the Hong Kong stock exchange with its shares priced at HKD 5.28 (USD 0.68) per share. The funding, which raised HKD 989.3 million (USD 126.8 million), places XtalPi as Hong Kong's third-largest IPO of the year at a market capitalization of USD 2.5 billion, according to Forbes.

  • The company has not disclosed the intended use of the procured funds. 

  • Analyst QuickTake: The public listing has been in the cards for XtalPi for quite a while, prompting it to raise a whopping USD 400 million in Series D funding in August 2021 . Having initially planned to go public in the US in May 2021, the company shifted plans to list on the Hong Kong stock market and filed for an IPO in December 2023 , owing to a new rule introduced in March 2023 that allowed "specialist technology companies” to get listed. Notably, fellow Chinese AI drug discovery company Hong Kong-based Insilico Medicine also filed for an IPO on the Hong Kong stock market in June 2023; however, XtalPi beat Insilico to it, as the latter had to submit an updated prospectus in April 2024.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.